Irofulven in Treating Patients With Stage IV Melanoma

NCT00005968 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

DRUG: irofulven

Sponsor

University of Colorado, Denver

Collaborators

[object Object]